[Asthma in children: recent comments and management].
Torbey
P H
PH
Service de Pédiatrie. Hôtel-Dieu de France, Beyrouth, Liban. ph@torbey.net
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000465:Algorithms; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D002669:Child Welfare; D002675:Child, Preschool; D003663:Decision Trees; D003937:Diagnosis, Differential; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D009017:Morbidity; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012720:Severity of Illness Index; D013256:Steroids; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D020024:Leukotriene Antagonists; D013256:Steroids